Literature DB >> 33758167

Identification of bis-benzylisoquinoline alkaloids as SARS-CoV-2 entry inhibitors from a library of natural products.

Chang-Long He1, Lu-Yi Huang1, Kai Wang1, Chen-Jian Gu2, Jie Hu1, Gui-Ji Zhang1, Wei Xu2, You-Hua Xie3,4, Ni Tang5, Ai-Long Huang6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33758167      PMCID： PMC7985570          DOI： 10.1038/s41392-021-00531-5

Source DB:  PubMed          Journal:  Signal Transduct Target Ther        ISSN： 2059-3635


× No keyword cloud information.
  4 in total

1.  Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: evidence for interaction at the diltiazem-binding site.

Authors:  J P Felix; V F King; J L Shevell; M L Garcia; G J Kaczorowski; I R Bick; R S Slaughter
Journal:  Biochemistry       Date:  1992-12-01       Impact factor: 3.162

Review 2.  Coronavirus membrane fusion mechanism offers a potential target for antiviral development.

Authors:  Tiffany Tang; Miya Bidon; Javier A Jaimes; Gary R Whittaker; Susan Daniel
Journal:  Antiviral Res       Date:  2020-04-06       Impact factor: 5.970

3.  Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.

Authors:  Zharko Daniloski; Tristan X Jordan; Hans-Hermann Wessels; Daisy A Hoagland; Silva Kasela; Mateusz Legut; Silas Maniatis; Eleni P Mimitou; Lu Lu; Evan Geller; Oded Danziger; Brad R Rosenberg; Hemali Phatnani; Peter Smibert; Tuuli Lappalainen; Benjamin R tenOever; Neville E Sanjana
Journal:  Cell       Date:  2020-10-24       Impact factor: 41.582

4.  Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.

Authors:  Bette Korber; Will M Fischer; Sandrasegaram Gnanakaran; Hyejin Yoon; James Theiler; Werner Abfalterer; Nick Hengartner; Elena E Giorgi; Tanmoy Bhattacharya; Brian Foley; Kathryn M Hastie; Matthew D Parker; David G Partridge; Cariad M Evans; Timothy M Freeman; Thushan I de Silva; Charlene McDanal; Lautaro G Perez; Haili Tang; Alex Moon-Walker; Sean P Whelan; Celia C LaBranche; Erica O Saphire; David C Montefiori
Journal:  Cell       Date:  2020-07-03       Impact factor: 66.850
  4 in total
  13 in total

1.  [Progress in the study of antiviral activity of cepharanthine against SARS-CoV-2].

Authors:  H Fan; K Liu; B Hong; S He; P Han; M Li; S Wang; Y Tong
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-06-20

2.  Bis-Benzylisoquinoline Alkaloids Inhibit Porcine Epidemic Diarrhea Virus In Vitro and In Vivo.

Authors:  Shijuan Dong; Ruisong Yu; Xiaoting Wang; Bingqing Chen; Fusheng Si; Jiaming Zhou; Chunfang Xie; Zhen Li; Daojing Zhang
Journal:  Viruses       Date:  2022-06-06       Impact factor: 5.818

Review 3.  Alkaloids as Potential Phytochemicals against SARS-CoV-2: Approaches to the Associated Pivotal Mechanisms.

Authors:  Mohammad Bagher Majnooni; Sajad Fakhri; Gholamreza Bahrami; Maryam Naseri; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-13       Impact factor: 2.629

Review 4.  Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions.

Authors:  Priyanka Saha; Subhankar Bose; Amit Kumar Srivastava; Anis Ahmad Chaudhary; Rajiv Lall; Sahdeo Prasad
Journal:  Molecules       Date:  2021-11-10       Impact factor: 4.411

Review 5.  Screening S protein - ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19.

Authors:  Le-le Ma; Hui-Min Liu; Xue-Mei Liu; Xiao-Yu Yuan; Chao Xu; Fang Wang; Jun-Zhi Lin; Run-Chun Xu; Ding-Kun Zhang
Journal:  Eur J Med Chem       Date:  2021-10-04       Impact factor: 6.514

Review 6.  Natural Products and Nanotechnology Against Coronavirus Disease 2019.

Authors:  Ning Zeng; Xue Chen; Zeming Liu
Journal:  Front Chem       Date:  2022-02-10       Impact factor: 5.221

Review 7.  Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies.

Authors:  Qi Xiang; Linhao Li; Jie Wu; Miao Tian; Yang Fu
Journal:  Microbiol Res       Date:  2022-02-16       Impact factor: 5.415

8.  A new screening system for entry inhibitors based on cell-to-cell transmitted syncytia formation mediated by self-propagating hybrid VEEV-SARS-CoV-2 replicon.

Authors:  Na Li; Xiao-Ling Chen; Qi Li; Zhe-Rui Zhang; Cheng-Lin Deng; Bo Zhang; Xiao-Dan Li; Han-Qing Ye
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

Review 9.  Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics.

Authors:  Lennox Chitsike; Penelope Duerksen-Hughes
Journal:  Virol J       Date:  2021-07-23       Impact factor: 4.099

Review 10.  Possible Targets of Pan-Coronavirus Antiviral Strategies for Emerging or Re-Emerging Coronaviruses.

Authors:  Xue Li; Liying Zhang; Si Chen; Hongsheng Ouyang; Linzhu Ren
Journal:  Microorganisms       Date:  2021-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.